Corona Remedies Ltd
Company Profile
Business description
Corona Remedies Ltd is a pharmaceutical formulation company engaged in developing, manufacturing, and marketing products in women's healthcare, cardio-diabetes, pain management, urology, and other therapeutic areas. The company offers products across the following therapeutic areas: women's health, cardio-diabetes, pain management, urology, and others/multispecialty pharmaceuticals (comprising VMN, gastrointestinal, and respiratory). The company operates in only one reportable business segment, i.e., pharmaceuticals. It generates a substantial portion of its revenue from operations in certain therapeutic areas in India, with the majority coming from women's healthcare.
Contact
S. G. Highway, CORONA House
C - Mondeal Business Park, Near Gurudwara
Thaltej
AhmedabadGJ380 059
INDT: +91 7940233000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 March 2027
Employees
4,573
Stocks News & Analysis
stocks
Eli Lilly receives FDA approval to add another oral GLP-1 to market
stocks
Our top ASX picks in every sector
stocks
Which of the 3 giant AI IPOs should you buy?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,774.90 | 124.80 | -1.40% |
| CAC 40 | 7,962.39 | 0.00 | 0.00% |
| DAX 40 | 23,168.08 | 130.81 | -0.56% |
| Dow JONES (US) | 46,504.67 | 61.07 | -0.13% |
| FTSE 100 | 10,436.29 | 71.50 | 0.69% |
| HKSE | 25,116.53 | 177.50 | -0.70% |
| NASDAQ | 21,879.18 | 38.23 | 0.18% |
| Nikkei 225 | 52,938.62 | 475.35 | 0.91% |
| NZX 50 Index | 12,902.15 | 76.28 | 0.59% |
| S&P 500 | 6,582.69 | 7.37 | 0.11% |
| S&P/ASX 200 | 8,579.50 | 105.50 | -1.21% |
| SSE Composite Index | 3,919.29 | 29.27 | -0.74% |